Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer

This study has been terminated.

( Interim analysis revealed that only 1 patient had a partial response. )

Study NCT00281021 Information provided by James Graham Brown Cancer Center

First Received: January 23, 2006 Last Updated: April 7, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	December 2010
Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)